Startup Xagenic Receives $1.1M to Commercialize Chip-based MDx Technology | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Canadian startup Xagenic today announced it has been awarded C$1 million (US$1.1 million) by the Ontario Ministry of Research and Innovation (MRI), which the company will use to commercial its chip-based molecular diagnostic technology.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.